Accès à distance ? S'identifier sur le proxy UCLouvain
Phase I trial of zalutumumab and irinotecan in metastatic colorectal cancer patients who have failed irinotecan- and cetuximab-based therapy
Primary tabs
Document type | Communication à un colloque (Conference Paper) – Présentation orale avec comité de sélection |
---|---|
Access type | Accès restreint |
Publication date | 2009 |
Language | Anglais |
Conference | "45th Annual Meeting of the American-Society-of-Clinical-Oncology", (United-States) Orlando, Florida (du 29/05/2009 au 02/06/2009) |
Journal information | "Journal of Clinical Oncology" - Vol. 27, no. 15, p. e15028 (2009) |
Peer reviewed | yes |
issn | 0732-183X |
e-issn | 1527-7755 |
Publisher | American Society of Clinical Oncology ((United States) Alexandria) |
Publication status | Publié |
Affiliations |
UCL
- MD/MINT - Département de médecine interne UCL - (SLuc) Unité d'oncologie médicale |
Links |
Bibliographic reference | Mano, Max S. ; Hendlisz, Alain ; Machiels, Jean-Pascal ; Ehrnrooth, E. ; Aladdin, H. ; et. al. Phase I trial of zalutumumab and irinotecan in metastatic colorectal cancer patients who have failed irinotecan- and cetuximab-based therapy.45th Annual Meeting of the American-Society-of-Clinical-Oncology ((United-States) Orlando, Florida, du 29/05/2009 au 02/06/2009). In: Journal of Clinical Oncology, Vol. 27, no. 15, p. e15028 (2009) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/58709 |